The 7th Annual EMBL Australia PhD Course is set to take place 11-15 July 2022 in Melbourne. 

This special edition, one-week course is modelled on the pre-doc training program at the prestigious European Molecular Biology Laboratory (EMBL), and it covers the latest ideas and advances in molecular biology and the life sciences

There will be multiple keynote speakers throughout the course, with a special welcome from Prof. James Whisstock (Scientific Head of EMBL Australia). Daily sessions comprise both lectures and practical workshops and are hosted by leading Australian and international scientists.

Students who applied in 2020, have been invited to participate in this year’s course. As many of these students have been working hard towards completing their PhD, the course is taking a new shape, catering content to 2nd and 3rd year students. 

The course will take place from 11 to 15 July 2022, (arrival on 10 July) at Monash University. There is no fee to attend and EMBL Australia will provide accommodation in Melbourne, as well as most meals.

RESEARCH AREAS COVERED WILL INCLUDE:

  • Structural and synthetic biology
  • Drug discovery and translation
  • Genomics and artificial intelligence
  • Regeneration and biomedical engineering
  • Microscopy and molecular

Further topics covered include:

  • Social media and the life sciences
  • Science integrity
  • Careers outside of academia
  • Diversity and inclusion
  • The course also includes visits to research facilities on site.

To stay up-to-date with future opportunities and to apply for next year’s course, subscribe to our newsletter or follow EMBL Australia on Facebook or Twitter.

Please direct any queries to: student.admin@emblaustralia.org.

Sponsors

We’d like to thank our key sponsor for this year’s PhD Course, MedChem Express. 

MedChemExpress (MCE) is dedicated to enabling success in biomedical research and drug discovery by offering a wide range of high-quality research products including life-science reagents, reference compounds, APIs and natural compounds. Since 2008, MCE has helped researchers worldwide in making considerable accomplishments that are featured in top journals and pharmaceutical patents. Currently, MCE works together with 500+ global partners and takes pride in supplying highest-grade inhibitors, agonists, and drug screening libraries. MCE functions through a customer-oriented approach, providing customised service and products to meet the needs while continually helping to find novel ways to enhance human lives.

 

Please get in touch with us for more information.